Latest News about IBB
Recent news which mentions IBB
   Chart of the Week: What Sector Looks Healthiest to Advisors
   
  
  
  November 10, 2022
  From ETF Trends
 
   ‘Just so full of autocracies’: For the Freedom 100 Emerging Markets ETF, outperformance in 2022 goes beyond nixing China
   
  
  
  November 03, 2022
  From MarketWatch
 
   Provention Bio's Second Try, Apellis's Eye Disorder Drug Review, 3 Adcom Verdicts And More: November's Key PDUFA Catalysts Biotech Investors Must Know
   
  
  
  November 01, 2022
  From Benzinga
 
   These 4 ETFs Feature on CNBC's 'Final Trades'
   
  
  
  October 27, 2022
  From Benzinga
 
   SBIO Rallied While Major Indexes Declined Last Week
   
  
  
  October 04, 2022
  From ETF Trends
 From Benzinga
 
   The 7 Best Stocks to Buy to Tap Into a Hidden Bull Market
   
  
  
  September 27, 2022
  From InvestorPlace
 
   SBIO Outpaced XBI, IBB in Volatile Last Week
   
  
  
  September 21, 2022
  From ETF Trends
 From MarketWatch
 
   The Best Biotech Stock to Own in September
   
  
  
  September 06, 2022
  From Motley Fool
 
   SBIO Was ALPS’ Top Performing ETF in August
   
  
  
  September 01, 2022
  From ETF Trends
 From Benzinga
 
   Biotech ETFs Are on the Mend
   
  
  
  August 19, 2022
  From ETF Trends
 
   SBIO Rallies on M&A Announcements
   
  
  
  August 10, 2022
  From ETF Trends
 From Benzinga
 
   Biotech Daily: Regulatory Setback For CorMedix, Mersana & GSK In Cancer Pact, BARDA Funding For Opioid Overdose Hopeful
   
  
  
  August 09, 2022
  From Benzinga
 
   Biotech Daily: Thumbs Down For Acadia's Antipsychotic Drug, Akebia Fails COVID-19 Study, Kazia's Encouraging Data In Brain Metastases
   
  
  
  August 05, 2022
  From Benzinga
 From Benzinga
 From Benzinga
 
   Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study
   
  
  
  August 02, 2022
  From Benzinga
 
   Daily Biotech Pulse: Celyad Resumes Colorectal Cancer Trial, Setback For Otonomy, AstraZeneca Halts Phase 3 Head, Neck Cancer Trial
   
  
  
  August 01, 2022
  From Benzinga
 From Benzinga
 From Benzinga
 From Benzinga
 From Benzinga
 From Benzinga
 From Benzinga
 
   Market Predictions 2022: When Will Stocks Go Back Up?
   
  
  
  July 22, 2022
  From InvestorPlace
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
